Search Results 631-640 of 17571 for Conjunctiva

  1. The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma - Mayo Clinic

    About this study. This proposal is for a pilot study comparing volumes of 18F-DOPA-PET avidity with contrast enhancement and T2 FLAIR on MRI.

  2. Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

    The purpose of this study is to determine the maximum tolerated dose of the combination of ABT-888 and weekly topotecan in adult patients with advanced solid ...

  3. Vaginal cancer - Doctors and departments - Mayo Clinic

    Learn about the symptoms of this rare type of cancer. Treatments for cancer of the vagina include surgery, radiation therapy and chemotherapy.

  4. Publications - Jorge M. Pascual, M.D. - Mayo Clinic

    Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. Stem Cells Transl Med. 2022 Jul 20; 11 ...

  5. Chordoma - Doctors and departments - Mayo Clinic

    Find out about this rare type of bone cancer. Learn about innovative chordoma treatments, including minimally invasive surgery and proton therapy.

  6. Return of Results of Pharmacogenomic Testing for Genes Involved in Metabolism of 5FU and Capecitibine - Mayo Clinic

    About this study. A group of Mayo Clinic Biobank participants were genotyped for genetic variants as part of a separate study and a subset were found to be ...

  7. Meningioma - Doctors and departments - Mayo Clinic

    This is the most common type of tumor that forms in the head and may affect the brain. Find out about symptoms, diagnosis and treatment.

  8. Radiology - Clinical trials

    The purpose of this study is to to examine the ability of photon counting computed tomography (PCCT) to reduce calcium blooming and beam-hardening artifacts ...

  9. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. First-in-Human Study of FLX925 in Subjects with Relapsed or Refractory Acute Myeloid Leukemia - Mayo Clinic

    About this study. This first-in-human clinical trial is a Phase 1/1b, open-label, sequential-group, dose-escalation and cohort expansion study evaluating ...